"Fennec Announces Issuance of U.S. Patent for PEDMARK™"
about Fennec Pharmaceuticals In..
Notified: 06:01 EDT at $6.56
"ASLAN Pharmaceuticals Completes Enrolment in Second Cohort and Opens New Sites in US and Australia in ASLAN004 Atopic Dermatitis Study"
about ASLAN Pharmaceuticals Lim..
Notified: 06:01 EDT at $1.46
"Precision BioSciences and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate PBCAR269A in Combination with Nirogacestat in..."
about Precision BioSciences, In..
Notified: 07:00 EDT at $5.95
"Agios Announces Final Overall Survival Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Previously Treated IDH1-Mutant C..."
about Agios Pharmaceuticals, In..
Notified: 07:00 EDT at $38.46
"Cyclacel Announces Fadraciclib Abstract Selected for Oral Presentation in the Late Breaking and Best Proffered Paper Session at the 32nd EOR..."
about Cyclacel Pharmaceuticals,..
Notified: 07:01 EDT at $3.74
"CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidney..."
about CollPlant Biotechnologies..
Notified: 07:01 EDT at $8.70
"Crinetics Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA for CRN04777 for the Treatment of Congenital Hyperinsulinism"
about Crinetics Pharmaceuticals..
Notified: 07:30 EDT at $15.77
"BridgeBio Pharma’s Calcilytix Therapeutics Initiates Phase 2 Study Of Encaleret For Autosomal Dominant Hypocalcemia Type 1 (ADH1)"
about BridgeBio Pharma, Inc.
Notified: 07:30 EDT at $43.05
"ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19"
about ARCA biopharma, Inc.
Notified: 08:00 EDT at $5.54
"Onconova Therapeutics Announces Initiation of a Phase 1 Clinical Trial of ON 123300 in China by Partner HanX Biopharmaceuticals"
about Onconova Therapeutics, In..
Notified: 08:01 EDT at $0.38
"Biocept Announces that Highmark Has Made a Positive Coverage Determination on Target Selector™ Liquid Biopsy"
about Biocept, Inc.
Notified: 08:01 EDT at $4.80
"I-Mab Announces China NMPA Clearance for Phase 1 Clinical Trial of Lemzoparlimab in Relapsed or Refractory Advanced Lymphoma"
Notified: 08:01 EDT at $36.66
"Oncternal Therapeutics Announces Presentation of Interim Phase 1 Clinical Trial Data for TK216 in Patients with Relapsed/Refractory Ewing Sa..."
about Oncternal Therapeutics, I..
Notified: 08:01 EDT at $2.13
"PolarityTE Receives NIH Grant for a Point-of-Care Device to Treat Chronic Wounds"
about PolarityTE, Inc.
Notified: 08:02 EDT at $1.06
"AngioDynamics Announces Commercial Launch of Auryon Atherectomy System in United States"
about AngioDynamics, Inc.
Notified: 08:02 EDT at $9.97
"TRACON Pharmaceuticals Highlights Updated Envafolimab Clinical Results in MSI-H/dMMR Colorectal Cancer"
about TRACON Pharmaceuticals, I..
Notified: 08:05 EDT at $6.30
"Liminal BioSciences Provides Update on Progress on BLA for Ryplazim®(plasminogen)"
about Liminal BioSciences Inc.
Notified: 08:18 EDT at $12.50
"XBiotech Developing True Human Antibody Combination as Candidate Treatment for Influenza-COVID-19 Co-Infections"
about XBiotech Inc.
Notified: 08:20 EDT at $22.46
"Exagen Launches Test to Aid in the Detection of ANCA-Associated Vasculitis (AAV)"
about Exagen Inc.
Notified: 08:25 EDT at $12.75
"Applied DNA Enters into Supply Agreement with ITW Pillar Technologies to Bring CertainT® Platform to Textiles Including Those Used in Person..."
about Applied DNA Sciences, Inc..
Notified: 08:31 EDT at $7.99
"DarioHealth and HMC HealthWorks Announce Partnership Agreement"
about DarioHealth Corp.
Notified: 08:31 EDT at $17.97
"VivoPower International PLC Announces Non-Binding LOI to Acquire 51% Shareholding in Tembo 4x4 e-LV B.V."
about VivoPower International P..
Notified: 09:00 EDT at $9.20
"Misonix Enters Into Exclusive Supply and Distribution Agreement With Gunze Limited for TheraGenesis® Bilayer Wound Matrix"
about MISONIX, Inc.
Notified: 10:00 EDT at $13.07
"Hoth Therapeutics Enters into Sponsored Research Agreement for On-the-Go COVID-19 Testing Device"
about Hoth Therapeutics, Inc.
Notified: 10:04 EDT at $2.56
"Exelixis Announces Results From Two Renal Cell Carcinoma Cohorts of the COSMIC-021 Trial of Cabozantinib in Combination With Atezolizumab"
about Exelixis, Inc.
Notified: 10:20 EDT at $25.80
"OnKure and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Combination of OKI-179 and Binimetinib"
about Pfizer, Inc.
Notified: 11:01 EDT at $35.63
Notice: Price change for each notified stock are being tracked by Preticks after signal notification and given stock price change analysis in this daily summary is being calculated accordingly. You can explore details for each notified signal in daily detailed performance analysis page.